- AstraZeneca - Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide
- About Our Company - AstraZeneca
With more than 2,600 employees from 70 countries, our vibrant Gothenburg site helps support the entire life-cycle of AstraZeneca medicines, from drug discovery and clinical trials, through to global commercialisation and product maintenance
- Articles - AstraZeneca
Get the latest news and updates from AstraZeneca, including articles covering Covid-19, Sustainability, Partnering, Science, Corporate and Finance
- Press Releases - AstraZeneca
Find press releases and media updates covering our latest science news, alongside AstraZeneca's financial, corporate, partnering and sustainability updates
- Introducing AstraZeneca R D
Introducing AstraZeneca R D We are driven by science, united by science, and every day, we push the boundaries of science to deliver life-changing medicines What science can do We are never complacent about scientific discovery and development, always pushing our R D productivity, searching for new knowledge and the next breakthrough
- A timeline of our company history | AstraZeneca
AstraZeneca was founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC This strategic merger combined each company’s strengths to drive scientific breakthroughs and bring innovative solutions to patients around the globe
- AstraZeneca Andean region
Respiratorio Oncología Enfermedades Raras ¿Quieres conocer más sobre AstraZeneca?
- Pipeline - AstraZeneca
AstraZeneca’s deep pipeline of medicines focusing on their key therapeutic areas
|